To investigate whether MPC1 inhibition increases glycolysis or reduces OXPHOS in tumor cells, we measured ECAR and OCR in PDOs treated with the MPC1 small molecule inhibitor UK-5099. This evidence concerns the gene MPC1 and neoplasm.